FDA Approved: NADOLOL — Supplemental Application (Alembic Pharmaceuticals Limited)

View source ↗

Summary

The FDA approved a supplemental application for Nadolol from Alembic Pharmaceuticals Limited, expanding access to this generic beta-blocker.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina Pectoris
• Cardiac Arrhythmia
• Hypertension
• Portal Hypertension

Drugs mentioned

• Nadolol (Nadolol)

Snippet

SUPPL AP for NADOLOL (NADOLOL)